The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Immune-Inflammatory Parameters in COVID-19 Cases: A Systematic Review and Meta-Analysis
Open accessAbstract
Background The recent outbreak of coronavirus disease 2019 (COVID-19) has been rapidly spreading on a global scale and posed great threat to human health. Acute respiratory distress syndrome, characterized by a rapid onset of generalized inflammation, is the leading cause of mortality of patients with COVID-19. Thus, we aimed to explore the effect of risk factors on the severity of the disease, focusing on immune-inflammatory parameters which represent the immune status of patients. Methods A comprehensive systematic search for relevant studies published up to April 2020 was performed by using PubMed, Web of Science, EMBASE, China National Knowledge Internet (CNKI) databases. After extracting all available data of immune-inflammatory indicators, we statistically analyzed the risk factors of severe and nonsevere COVID-19 patients with meta-analysis. Results A total number of 4911 patients from 29 studies were finally included in the meta-analysis. The results demonstrated that severe patients tend to present higher level of white blood cell (WBC), neutrophil, neutrophil-lymphocyte ratio (NLR), procalcitonin (PCT), C-reaction protein (CRP), erythrocyte sedimentation rate (ESR) and Interleukin-6 (IL-6) and decreased number of total lymphocyte and lymphocyte subtypes such as CD4+ T lymphocyte and CD8+ T lymphocyte compared to the nonsevere patients. In addition, WBC count>10ⅹ109/L, lymphocyte count0.5ng/mL, CRP>10 mg/L were risk factors for disease progression in patients with COVID-19 (WBC count>10ⅹ109/L: OR=2.92, 95%CI: 1.96-4.35; lymphocyte count0.5ng/mL: OR=6.33, 95%CI: 3.97-10.10; CRP>10 mg/L: OR=3.51, 95%CI: 2.38-5.16). Furthermore, we found that NLR, as a novel marker of systemic inflammatory response, can also help predict clinical severity in patients with COVID‐19 (OR=2.50, 95%CI: 2.04-3.06). Conclusions Immune-inflammatory parameters such as WBC, lymphocyte, PCT, CRP and NLR could imply the progression of COVID-19. NLR has taken both the levels of neutrophil and lymphocyte into account, indicating a more complete, accurate and reliable inspection efficiency; surveillance of NLR may help clinicians identify high risk COVID-19 patients at an early stage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NLR is also an inflammatory marker known to increase with the progression of the inflammatory reaction (17).”
From Mean platelet volume is the most valuable hematologic parameter in differentiating testicular torsion from epididymitis within the golden time (2022) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Wan, X., Wang, W., Liu, J., & Tong, T. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-135 · Cited by 11,735
Neutrophil Extracellular Traps Kill Bacteria
Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D. S., Weinrauch, Y., & Zychlinsky, A. (2004) · Science · doi:10.1126/science.1092385 · Cited by 10,268
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545 · cited 2×
“Studies included in the meta-analysis had to satisfy the following criteria: (1) the study was a clinical observation in humans; (2) the study included clinical signs of a COVID-19 patient; and (3) the study included baseline information regarding inflammation indicators, such as white blood cells, neutrophils, lympho…”
BackgroundMethodWu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775 · cited 1×
“Moreover, a previous retrospective study reported that a subgroup of patients with severe COVID-19 could have a dysregulation of the immune response that allows the development of viral hyperinflammation (8).”
BackgroundAzevedo, R. S. S., de Sousa, J. R., Araujo, M. T. F., Martins Filho, A. J., de Alcantara, B. N., Araujo, F. M. C., Queiroz, M. G. L., Cruz, A. C. R., Vasconcelos, B. H. B., Chiang, J. O., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-17765-5 · Cited by 3,478
The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients
Yang, A.-P., Liu, J.-P., Tao, W.-Q., & Li, H.-M. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106504 · Cited by 1,138
Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing
Wan, S., Xiang, Y., Fang, W., Zheng, Y., Li, B., Hu, Y., Lang, C., Huang, D., Sun, Q., Xiong, Y., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25783 · Cited by 982
Self-citationOnukwugha, E., Yong, C., Hussain, A., Seal, B., & Mullins, C. D. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-1 · Cited by 589
Cited by
Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors
Mazza, M. G., De Lorenzo, R., Conte, C., Poletti, S., Vai, B., Bollettini, I., Melloni, E. M. T., Furlan, R., Ciceri, F., Rovere-Querini, P., et al. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.07.037 · Cited by 1,804
Multisystem inflammatory syndrome in children: A systematic review
Ahmed, M., Advani, S., Moreira, A., Zoretic, S., Martinez, J., Chorath, K., Acosta, S., Naqvi, R., Burmeister-Morton, F., Burmeister, F., et al. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100527 · Cited by 597
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity
Osuchowski, M. F., Winkler, M. S., Skirecki, T., Cajander, S., Shankar-Hari, M., Lachmann, G., Monneret, G., Venet, F., Bauer, M., Brunkhorst, F. M., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00218-6 · Cited by 520
Retracted: Neutrophil/lymphocyte ratio—A marker of COVID‐19 pneumonia severity
(2020) · doi:10.1111/ijcp.13698 · Cited by 88
RetractedLee, H. Y., Lim, D. G., Chung, H. S., Kim, J. S., Yu, S. H., Kim, M. S., Hwang, E. C., Oh, K. J., Kim, S. O., Jung, S. I., et al. (2022) · Translational Andrology and Urology · doi:10.21037/tau-21-1112 · Cited by 14
Metadata
- Authors
- Feng, X., Li, S., Sun, Q., Zhu, J., Chen, B., Xiong, M., & Cao, G.
- Venue
- Frontiers in Medicine
- Publisher
- Frontiers Media SA
- Published
- 2020-06-09
- Volume
- 7
- Pages
- 301-301
- ISSN
- 2296-858X (ISSN-L)
- OpenAlex
- W3034448873
- Cited by
- 213
- References
- 11
- FWCI
- 2.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.